← Browse entries

TAL1

S. cerevisiae

sedoheptulose-7-phosphate:D-glyceraldehyde-3-phosphate transaldolase TAL1

What the model saw

Gene: TAL1
Organism: Saccharomyces cerevisiae
Known functions: sedoheptulose-7-phosphate:D-glyceraldehyde-3-phosphate transaldolase TAL1. transaldolase activity.
View unredacted entry
sedoheptulose-7-phosphate:D-glyceraldehyde-3-phosphate transaldolase TAL1. transaldolase activity.

Solver output

Predicted influence
Pro-longevity
Confidence
72%
Mechanism
Other
Reasoning

TAL1 encodes transaldolase, which catalyzes the transfer of a dihydroxyacetone unit from sedoheptulose-7-phosphate to glyceraldehyde-3-phosphate in the non-oxidative branch of the pentose phosphate pathway (PPP). This reaction is critical for regenerating fructose-6-phosphate and glyceraldehyde-3-phosphate, thereby sustaining flux through the PPP. The PPP is the primary source of NADPH in yeast, which is essential for maintaining glutathione and thioredoxin in their reduced states, supporting antioxidant defense. Additionally, the PPP produces ribose-5-phosphate for nucleotide biosynthesis, supporting genomic integrity. Loss of transaldolase activity has been shown to reduce NADPH availability and increase oxidative stress, which accelerates aging; conversely, its normal function supports redox homeostasis and is associated with extended replicative and chronological lifespan in yeast.

Key pathways
pentose phosphate pathwayNADPH-dependent redox homeostasisoxidative stress resistance
Longevity influence
Anti-longevity
Lifespan effect
Increase

GenAge curators classify each gene's normal function as promoting (Pro-Longevity) or opposing (Anti-Longevity) longevity, based on synthesis across studies. Loss-of-function effects can vary from this depending on the manipulation.

Advisor judgment

Answer
Incorrect
Mechanism
Incorrect
Reasoning quality
2/5
Failure mode
Confident wrong
Notes

The model predicted pro_longevity with 0.72 confidence, but the ground truth is anti_longevity. The model's reasoning about TAL1's role in the pentose phosphate pathway and NADPH production is generally accurate biochemically, but the conclusion drawn is incorrect. The model assumed that because TAL1 supports redox homeostasis, it must be pro-longevity. However, in yeast, TAL1 is actually anti-longevity, meaning its deletion or reduction extends lifespan. The model fabricated the claim that "loss of transaldolase activity accelerates aging" without actual evidence, and incorrectly stated it is "associated with extended replicative and chronological lifespan." The mechanistic reasoning, while plausible-sounding, leads to the wrong conclusion and appears to be confabulated rather than based on actual experimental data.

Raw API responses

solver

{
  "reasoning": "TAL1 encodes transaldolase, which catalyzes the transfer of a dihydroxyacetone unit from sedoheptulose-7-phosphate to glyceraldehyde-3-phosphate in the non-oxidative branch of the pentose phosphate pathway (PPP). This reaction is critical for regenerating fructose-6-phosphate and glyceraldehyde-3-phosphate, thereby sustaining flux through the PPP. The PPP is the primary source of NADPH in yeast, which is essential for maintaining glutathione and thioredoxin in their reduced states, supporting antioxidant defense. Additionally, the PPP produces ribose-5-phosphate for nucleotide biosynthesis, supporting genomic integrity. Loss of transaldolase activity has been shown to reduce NADPH availability and increase oxidative stress, which accelerates aging; conversely, its normal function supports redox homeostasis and is associated with extended replicative and chronological lifespan in yeast.",
  "confidence": 0.72,
  "key_pathways": [
    "pentose phosphate pathway",
    "NADPH-dependent redox homeostasis",
    "oxidative stress resistance"
  ],
  "mechanism_class": "other",
  "longevity_influence": "pro_longevity"
}

advisor

{
  "notes": "The model predicted pro_longevity with 0.72 confidence, but the ground truth is anti_longevity. The model's reasoning about TAL1's role in the pentose phosphate pathway and NADPH production is generally accurate biochemically, but the conclusion drawn is incorrect. The model assumed that because TAL1 supports redox homeostasis, it must be pro-longevity. However, in yeast, TAL1 is actually anti-longevity, meaning its deletion or reduction extends lifespan. The model fabricated the claim that \"loss of transaldolase activity accelerates aging\" without actual evidence, and incorrectly stated it is \"associated with extended replicative and chronological lifespan.\" The mechanistic reasoning, while plausible-sounding, leads to the wrong conclusion and appears to be confabulated rather than based on actual experimental data.",
  "failure_mode": "confident_wrong",
  "answer_correct": false,
  "mechanism_correct": false,
  "reasoning_quality": 2,
  "ground_truth_questionable": false
}